'Hot' Alzheimer's Market is Promising for Biotech with 'Novel' Drug Candidate

Disclosures from Mackie Research, ProMIS Neurosciences Inc., Update, Nov. 13, 2017

RELEVANT DISCLOSURES APPLICABLE TO: PROMIS NEUROSCIENCES INC

1. Relevant disclosures required under IIROC Rule 3400 applicable to companies under coverage discussed in this research report are available on our web site at www.mackieresearch.com.

ANALYST CERTIFICATION

Each analyst of Mackie Research Capital Corporation whose name appears in this report hereby certifies that (i) the recommendations and opinions expressed in this research report accurately reflect the analyst’s personal views and (ii) no part of the research analyst’s compensation was or will be directly or indirectly related to the specific conclusions or recommendations expressed in this research report.